Introduction
Acetylcholinesterase (AChE) is a critical enzyme which terminates neurotransmission at cholinergic synapses. Three mature mRNA transcripts, namely 'synaptic' AChE-S, 'erythrocytic' AChE-E and 'readthrough' AChE-R, can be spliced from AChE gene. AChE expression was once thought to be tissue specific; however, it has been shown that AChE is also expressed in tissues devoid of cholinergic responses (Small et al., 1996) and in several types of hematopoietic cells (Tranum-Jensen and Behnke, 1981; Grisaru et al., 1999) , indicating potential functions beyond the termination of cholinergic transmission. The increasing evidence has shown that AChE may be involved in apoptosis. Transfection with AChE leads to an increase of apoptosis in retinal cells (Zhang et al., 2002) . The induction of AChE expression can be found during apoptosis in various cell types and the anti-sense oligonucleotides of AChE may prevent apoptosis (Zhang et al., 2002) . Silencing of the AChE gene with small interfering RNA (siRNA) is able to inhibit the interaction between apoptotic protease-activating factor-1 (Apaf-1) and cytochrome c, and to prevent their downstream events of apoptosis (Park et al., 2004) .
c-Jun NH2-terminal kinases (JNK), a family of stressactivated protein kinases, may be activated and contribute to apoptotic signal transduction when cells are exposed to multiple forms of stress such as growth factor withdrawal, excitoxic stress, ultraviolet radiation (Kurinna et al., 2004; Hamdi et al., 2005; Khelifi et al., 2005) . The target proteins of JNK have the transcription factor c-Jun, which is phosphorylated and activated by JNK, forkhead transcriptional factor which is phosphorylated by JNK and then translocates to nucleus for regulating the transcription of some target genes, and some pro-apoptotic or anti-apoptotic proteins such as Bax and Bcl-2 (Kops et al., 2002; Essers et al., 2004) . The activated c-Jun can homodimerize with itself or heterodimerize with another transcription factor such as c-Fos to form the transcription factor AP-1 and regulate gene expression (Cuadrado et al., 2004) .
Although AChE plays an important role in apoptosis induction, the regulation of AChE during apoptosis and the relationships between this enzyme and classical apoptotic pathways remain to be elucidated. AChE expression in the cortex of the thymus may be induced by stress stimuli, and in the promoter region of AChE gene, there are GRE, AP-1, Sp-1 transcription factors binding sites (Meshorer et al., 2004) . Therefore, we hypothesized that JNK/c-Jun pathway might mediate AChE expression in apoptotic process. Both etoposide and excisanin A, two anti-cancer agents, can induce apoptosis and activate JNK/c-Jun pathway in colon cancer cell line SW620. In present study, the models would be utilized to investigate whether the JNK pathway mediates AChE expression during apoptosis.
Results

Induction of apoptosis by etoposide and excisanin A in SW620 cells
Treatment of SW620 cells for 3 days with increasing concentrations of both etoposide and excisanin A resulted in growth inhibition. IC 50 values of etoposide and excisanin A inhibiting growth of SW620 cells were 43.05 mg/ml and 2.36 mg/ml, respectively. Furthermore, to determine whether etoposide or excisanin A would induce apoptosis, Annexin V staining was employed for detecting apoptosis. As shown in Figure 1 (a), Annexin V-positive cells increased from 1.9 to 40.7, 42.9, 43.9% in SW620 cells treated for 36 h with 20, 40, 80 mg/ml of etoposide, respectively. Following treatment of SW620 cells with 2.5 mg/ml excisanin A, the early apoptotic rates increased from 1.9 to 17.2% after 12 h and up to 20.5% after 24 h (Figure 1(b) ). To further confirm apoptosis induced by etoposide and excisanin A, caspase-3 and PARP cleavages were detected by Western blot analysis. The results showed that pro-caspase-3 was cleaved to yield a 17 KDa fragmentation and PARP was cleaved into 89 KDa fragmentation following etoposide, excisanin A treatment (Figure 2a and b) . AChE expression regulated by JNK R Deng et al revealed that phosphorylated SAPK/JNK and phosphorylated-c-Jun time-dependently increased after treatments (Figure 3a and b) . Furthermore, the ERK and p38 of MAPKs were also examined. The results showed that etoposide hardly affected the levels of phospho-p38 and phospho-ERK1/2 in SW620 cells (Figure 3a) . At the same time, it was found that excisanin A enhanced the levels of phospho-p38 but not the levels of phospho-ERK in SW620 cells (Figure 3b ). The protein expressions of JNK, p38 and ERK1/2 did not significantly change in SW620 cells exposed to etoposide and excisanin A (Figure 3 ). Furthermore, both the agents also increased phosphorylation and protein expression of c-Jun (Figure 3 ).
Upregulation of AChE expression following etoposide and excisanin A AChE is involved in apoptosis induced by various stimuli. To determine whether AChE expression would be upregulated in SW620 cells exposed to etoposide and excisanin A, the protein expression, mRNA level of AChE and AChE variants were detected. With reverse transcriptase-polymerase chain reaction (RT-PCR) assay, it was found that only AChE-S variant mRNA time-dependently increased in SW620 cells, but AChE-R and AChE-E variants could not be detected following the treatments of etoposide and excisanin A (Figure 4b , d). With Western blot analysis, it was shown that AChE protein expression also time-dependently increased in the cells exposed to both the agents (Figure 4a , c).
SP600125 blocks upregulation of AChE induced by etoposide or excisanin A
To determine whether the activation of JNK is required for AChE expression in apoptosis elicited by etoposide or excisanin A, the cells was pre-treated with various concentrations of SP600125 (a JNK specific inhibitor) for 1 h and then exposed to etoposide or excisanin A. As shown in Figure 5b and d, the increased AChE mRNA levels were significantly inhibited by SP600125. On the other hand, the phosphorylation level of c-Jun and the induced AChE protein expression by the two agents were also blocked by SP600125 (Figure 5a , c), which was specially shown in a concentration-dependent reduction in AChE protein expression when the concentrations of SP600125 gradually increased in SW620 cells exposed to etoposide (Figure 5a ). Excisanin A was found in the above result to also enhance the level of phospho-p38 in SW620 cells. To investigate whether p38 is involved in this process, SW620 cells was pretreated with SB203580, a p38-specific inhibitor, for 1 h and then exposed to excisanin A. It was showed in Figure 5c and d that SB203580 failed to block AChE expression.
Silencing of JNK1/2 by siRNA blocks induction of AChE expression To further determine whether activation of JNK would be required for AChE expression during apoptosis, an additional approach, siRNA directed against a common sequence of JNK1 and JNK2 was used to inhibit JNK expression. Figure 6a and b showed that transient transfection with this siRNA led to efficient the downregulation of both JNK1 and JNK2. More importantly, the downregulation of JNK1/2 by siRNA not only efficiently inhibited the phosphorylation level of c-Jun but also dramatically prevented the AChE mRNA and protein expression induced by etoposide in SW620 cells.
Infection with Ad-DN-Jun blocks induction of AChE expression
SP600125 (a specific inhibitor of JNK pathway) and JNK-specific siRNA were shown in the above results to block AChE upregulation. However, an important downstream target of JNK is transcription factor cJun. We, thus, asked whether JNK pathway-mediated AChE expression was through c-Jun transcription factor. The adenovirus-mediated dominant negative cJun mutant (Ad-DN-Jun) infection was used to confirm this prediction. Adenovirus-mediated GFP (Ad-GFP) was used to detect the infection rate. The infection rate AChE expression regulated by JNK R Deng et al was about 85% (data not shown). As shown in Figure  7a and b, both etoposide-induced phosphorylation level of c-Jun and upregulation of AChE expression were inhibited in SW620 cells infected with Ad-DN-Jun.
Discussion
AChE expression is induced during apoptosis in various cell types by different apoptotic stimuli, and the blockage of AChE expression by antisense or siRNA can prevent apoptosis induction (4). Also, the silencing of the AChE gene by siRNA inhibits the interaction between Apaf-1 and cytochrome c, indicating that AChE may play a critical role in apoptosome (Park et al., 2004) . However, the regulation of AChE expression and the relationships between this enzyme and classical apoptotic molecules during apoptosis remain to be elucidated. In present study, to elucidate the regulation of AChE expression, the apoptotic models induced by two anti-cancer agents etoposide AChE expression regulated by JNK R Deng et al and excisanin A in SW620 cells were established firstly. Apoptosis, programmed cell death, is a fundamental mode of cell death. Phosphatidyl serine translocation to the cell surface is an indicator of early apoptotic cells (Zhu et al., 2002) . With Annexin V staining assay, both etoposide and excisanin A significantly increased the Annexin V-positive cells in SW620 cell line (Figure 1 (i) and (ii)). The activation of caspase-3 is required for lots of stimuli-induced apoptosis (Yin et al., 2005) . Both etoposide and excisanin A induced the cleavage of capspase-3 and PARP in SW620 cells, indicating that caspase-3 was activated during apoptosis induced by the two agents (Figure 2a and b) . Taken together, these results suggest that both etoposide and excisanin A may induce caspase-3-dependent apoptosis in SW620 cells. Using the above apoptotic models, it was found that both etoposide and excisanin A enhanced AChE expression in protein and mRNA levels as demonstrated by Western blot and RT-PCR assays and only AChE-S variant (Figure 4) , which offers another evidence for supporting the upregulation of AChE expression during apoptosis. We thus wanted to know which apoptotic pathways involved in the upregulation of AChE AChE expression regulated by JNK R Deng et al expression. JNK is commonly activated when cells are exposed to various stresses such as growth factor withdrawal, chemotherapeutics, ultraviolet and tumor necrosis factor (TNF-a) (Chen and Tan, 2000; Collett and Campbell, 2004; Zou et al., 2004; Kuntzen et al., 2005; Teraishi et al., 2005; Yin et al., 2005) . Furthermore, it has been shown that JNK contributes to apoptotic signal transduction in response to various stress stimuli (Tournier et al., 2000; Lei et al., 2002; Kirkland and Franklin, 2003; Lei and Davis, 2003; Eminel et al., 2004) . JNK can phosphorylate c-Jun on the sites (Ser63 and Ser73) and increase its transcriptional activity (Smeal et al., 1991) . In our apoptotic system, as shown in Figure 3 , both etoposide and excisanin A time-dependently enhanced the phosphorylation level of JNK and c-Jun in SW620 cells. c-Jun protein expression was also upregulated exposed to the agents. It may be due to increased the stability of phosphorylated c-Jun or transcription regulation by JNK pathway. Furthermore, the other two MAPK pathways, ERK and p38, were also detected to find whether the two agents interfered with the activation of the two pathways. It was found that etoposide hardly affected the levels of phospho-p38 and phospho-ERK1/2 in SW620 cells (Figure 3a) . However, excisanin A enhanced the levels of phospho-p38 in SW620 cells (Figure 3b ). Therefore, we wanted to know what relationships between the upregulation of AChE and JNK or p38 pathways. To elucidate the association between JNK activation and AChE expression, the JNK specific inhibitor SP600125 was used to inhibit JNK activity. After JNK activity was inhibited by SP600125, upregulation of AChE expression was blocked in protein and mRNA levels in SW620 cells exposed to the two agents ( Figure 5) . Furthermore, the siRNA directed against JNK1/2 blocked upregulation of AChE expression by the two agents in this cancer cell line ( Figure 6 ). As shown in Results, it was also found that excisanin A could enhance the phosporylation level of p38 MAP kinase. We asked whether p38 was involved in this process. However, we found that the upregulation of AChE expression by excisanin A was not affected by SB203580, a p38-specific inhibitor. Together, these findings indicate that upregulation of AChE expression during apoptosis is dependent of JNK activation but not p38.
c-Jun is a predominant target of JNK and may be phosphorylated by the activated JNK and then be activated for regulating the expression of some target genes. It has been reported that the AChE promoter contains AP-1, AP-2, GRE, binding sites (Getman et al., 1995; Perry et al., 2002; Cohen and Randall, 2004; Meshorer et al., 2004; Meshorer et al., 2005) . c-Jun and c-fos can form AP-1 transcription factor. To study whether c-Jun activation by JNK is involved in the upregulation of AChE expression during apoptosis, SW620 cells was transfected with Ad-DN-Jun. It was found that both etoposide-induced c-Jun phosphorylation and AChE expression were significantly blocked (Figure 7) . The results suggest that the activation of c-Jun is directly involved in the regulation of AChE expression during apoptosis.
In conclusion, etoposide and excisanin A, two anticancer agents, can induce the caspase-3-dependent apoptosis in SW620 cells. In these apoptotic models, it has been demonstrated that (i) the two agents can timedependently induce the upregulation of AChE expression and the activation of JNK/c-Jun pathway; (ii) both the inhibition of JNK activity with SP600125 and the depletion of JNK expression with siRNA inhibit the upregulation of AChE expression and (iii) Ad-DN-Jun can block the expression of AChE induced by the two agents. In addition, the above phenomena and mechanisms have also been shown in another anti-cancer agent squamocin-induced apoptosis in HL-60 cells (data not shown). Taken together, these findings suggest that the upregulation of AChE expression may be mediated by the JNK/c-Jun pathway during apoptosis, which not only offers for the first time the mechanism of regulation of AChE expression during apoptosis but also a novel mechanism of the anti-cancer agents.
Materials and methods
Drugs and reagents
Etoposide was purchased from Sigma (St Louis, MO, USA). Excisanin A from plant Largesepal Rabdosia was initially dissolved in 100% dimethylsulfoxide (DMSO) and stored at À201C (Gao et al., 2000; Zhu et al., 2002) . RPMI-1640 medium, DMSO and sodium dodeeyl sulfate (SDS) were purchased from Sigma. Anti-AChE antibody was purchased from BD Bioscience (San Jose, CA, USA) or Santa Cruz (Santa Cruz, CA, USA). Anti-caspase-3, anti-PARP, antiphospho-c-Jun, anti-actin, anti-c-Jun and horseradish peroxidase-conjugated second antibody were from Santa Cruz. JNK, Phospho-JNK, ERK, phospho-ERK, phospho-p38, p38 and ECL chemiluminescence reagents were obtained from Cell Signaling (Beverly, MA, USA). Annexin V-FITC apoptosis detection kit was purchased from Calbiochem (Darmstadt, Germany). Adenovirus-mediated dominant negative c-Jun (Ad-DN-Jun) is a gift from Professor Mingtao Li (Sun Yat-sen University Medical College). Colon cancer cell line SW620 was obtained from American Type culture collection (Rockville, MD, USA).
Measurement of cytotoxicity
Cells were seeded in 96-well-plate (Falcon, Lincon Park, NJ, USA) at the various density per well. On the next day, compounds were prepared at twofold dilutions in medium and incubated with the cells for 72 h till the cells of control grew 70% confluent. Cell viability was determined by 3(4,5-dimethylthiazol-2-yl)-2.5-diphenyl-tetrazolium bromide (MTT) assay. Briefly, MTT was dissolved and sterilized in phosphate-buffered soline (PBS) at 5 mg/ml and 10 ml was added into each well. The plates were incubated in incubator (371C, 5% CO 2 ) for 4 h and the medium was removed. Add DMSO 100 ml into each well to dissolve the dark blue crystal, shake the plate gently 5 min. The absorbance (570/650 nm) was measured to determine cell viability.
Annexin V-FITC/PI staining
Cells with different treatments were collected, resuspended with 10% 1640 medium, adjusted the cell suspension concentration to approximately 1 Â 10 6 cells/ml, and transferred 0.5 ml of cell suspension to a microfuge tube. After added 10 ml media binding reagent and 1.25 ml Annexin V-FITC, cells were incubated at room temperature for 15 min in the dark, then centrifuged and removed media. When resuspended in 0.5 ml cold 1 Â binding Buffer (10 mM HEPES, 150 mM NaCl, 2.5 mM CaCl 2 , 1 mM MgCl 2 , 20% BSA pH 7.4), cells were added 10 ml propidium iodide (30 mg/ ml), placing samples on ice and away from light. Apoptosis was analysed by flow cytometry (BD Company, USA) at the wavelength of 488 nm immediately.
Reverse transcription-polymerase chain reaction Total RNA was isolated by TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. For reverse transcription reaction, combined 2 mg RNA, 0.5 mg olig(dT) 15 and adjusted volume to 15 ml with DEPC-treated water, the mixture was incubated at 701C for 5 min and placed on ice. Then added 5 ml 5 Â M-MLV reaction buffer, 1.25 ml 4 Â dNTP (10 mM), 1 ml M-MLV (Promega, Madison, WI, USA, 200 m/ml), 0.625 ml RNaseOUTt (40 m/ ml) and adjusted volume to 25 ml with DEPC-treated water, incubated the tube at 421C for 60 min and terminated the reaction by incubating at 751C for 10 min. The product of the reverse transcriptase reaction was used for amplification of AChE and GAPDH cDNA (control), in the presence of Taq DNA polymerase, dNTP mix, PCR buffer (all from Invitrogen), downstream and upstream primers. Amplification conditions were denaturation at 941C for 30 s (5 min for the first cycle), annealing at 551C for 40 s and extension at 721C for 60 s (10 min for the last cycle) for 30-35 cycles. 10 ml of the 50 ml-amplification reaction mixtures was separated on a 1.21C agarose gel stained with ethidium bromide.
To detect the mRNA of the AChE (GenBank, accession number M55040) variants, the PCR primers were employed as follows: 1. 0 -ATGGGTGAAGCCTGGGCAGGTG-3 0 . Primer1 and 2 for AChE-S designed to generate a fragment of 482 bp. Primer1 and Primer3 for AChE-R designed to generate a fragment of 417bp. Primer1 and 4 for AChE-E designed to generate a fragment of 395 bp (Karpel et al., 1994) . We used the primer1 (5 0 -CCACCCATGGCAAATTCCATGGCA-3 0 ) and the primer 2 (5 0 -TCTAGACGGCAGGTCAGGTCCAC -C-3 0 ) to generate a 588 bp fragment of GAPDH (Genbank accession number NM002046.3) as internal control.
Western blot analysis
Lysates were prepared from 1 Â 10 6 cells by dissolving cell pellets in 100 ml of lysis buffer (20 mM Na 2 PO 4 (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% aprotinin, 1 mM phenymethysulfonyl fluoride, 10 mg/ml leupeptin, 100 mM NaF, and 2 mM Na 3 VO 4 ). Lysates were centrifuged at 12 000 r.p.m. for 10 min. The supernatant was collected. The protein content was determined using the Bio-Rad protein assay (Bio-Rad labortories, Hercules, CA, USA). SDS-PAGE sample buffer (10 mM Tris-HCl, pH 6.8, 2% SDS, 10% Glycerol, 0.2 M DTT) was added to lysates. Lysates were heated to 1001C for 5 min, and 40 mg of protein was loaded in each well of a 10-15% SDS-PAGE gel. Resolved proteins were electrophoretically transferred to nitrocellulose and incubated sequentially with primary antibody and horseradish peroxidase-conjugated second antibody. After washing, the bound antibody complex was detected using an ECL chemiluminescence reagent and XAR film (Kodak, Shanghai, China) as described by the manufactures (Zhu et al., 2005; Zhou et al., 2006) .
siRNA transfection
The target sequence for JNK1/2-specific siRNA was 5 0 -AAAAAG AAUGUCCUACCUUCU-3 0 (Genebank accession number NM002750.2) (Gururajan et al., 2005) , control siRNA (no silencing) and were synthesized by GenChem Co. One day before transfection, plate SW620 cells onto six-well plates with growth medium without antibiotics at a density of 1 Â 10 6 cells/well. When cells grew to a confluency of 50 on the second day, transfection was performed by using Opti-MEM media, lipofectamine2000 and JNK1/2 siRNA according to manufacturer's recommendations. The final concertration of JNK1/2 siRNA was 100 nM. After 6, the media was replaced with growth media without antibiotics and cells were treated with 40 mg/ml etoposide for 20 h. The cells were transfected with lipofectamine2000 as control.
Adenovirus-mediated dominant negative c-Jun mutant infection SW620 cells were grown in six-well culture plates to 60-70% confluence, then infected with Ad-DN-Jun. After a 24-h incubation period, the media was replaced with normal growth media and cells were treated with 40 mg/ml etoposide for 20 h and the cells were infected with Ad-GFP as control.
